Trial in Progress: A Phase 2 Study of Linvoseltamab for the Treatment of High-Risk Smoldering Multiple Myeloma (LINKER-SMM1)
Authors:
Open Access
- 2 November 2023
- journal article
- abstracts
- Published by American Society of Hematology in Blood
- Vol. 142 (Supplement) , 3393